Though cancer mortality rates have declined worldwide since the mid 1980s, upper aerodigestive (UADT) cancer, including esophageal squamous cell cancer (ESCC, predominant subtype of esophageal cancer) and tongue SCC (major site of oral cancer), remains deadly. Thus, clarification of pathogenetic mechanisms and new prevention strategies are urgently needed. Global dietary zinc (Zn) deficiency (ZD) is estimated to affect 30% of the population (4-73% across subregions), with higher rates in developing countries. Importantly, ZD increases the risk of UADT cancer. In the past six years we have made significant progress toward understanding the molecular role of Zn in UADT cancer development and prevention. Using unbiased whole genome expression profiling, bioinformatics, molecular pathology, and our well-characterized animal models, we have found that: (i) short-term dietary ZD in rats induces overexpression of proinflammation mediators, S100a8 and S100a9, associated with esophageal hyperplasia. Zn modulates the link between S100A8-RAGE interaction and downstream NF-kB/COX-2 signaling, evidence that Zn regulates an inflammatory pathway in early esophageal carcinogenesis;(ii) prolonged ZD induces a cancer-associated inflammatory gene signature that fuels ESCC and oral Zn replenishment reverses this signature and prevents ESCC. (iii) Zn- supplementation suppresses UADT tumor development in rats and tumor suppressor-deficient mouse strains on a Zn-sufficient diet through attenuation of inflammation, evidence that Zn has chemopreventive effects even in Zn-sufficient subjects;(iv) Using the nanoStringTM technology, we discovered that dietary ZD alters microRNA expression in a tissue-specific manner. The inflammatory ZD esophagus has a distinct microRNA gene signature with overexpression of oncogenic miR-31 and miR-21, resembling that in human ESCC/tongue SCC. In ZD rats esophageal miR-31 and miR-21 levels are directly associated with the appearance of ESCC. In situ hybridization study of miR-31 and miR-21 expression in rat/human tongue SCC reveals that their upregulation is cell type-specific and is Zn-therapy responsive.
In Aim 1, we test the hypothesis that dietary ZD bypasses the requirement for RAGE-signaling in sustaining inflammation and promotes forestomach carcinogenesis in Rage-/- mice by activating alternative inflammatory pathway(s).
In Aim 2, we dissect dietary Zn modulation of gene expression (microRNA, mRNA) in tongue cancer development and regression in carcinogen-treated rats.
In Aim 3, we test the hypothesis that in vivo inhibition of miR-21 in ZD rats that is induced by dietary ZD in stroma might offset the inflammation-promoting effect of ZD and inhibit ESCC.
In Aim 4, we determine the requirement for Zn in the prevention of UADT cancer by investigating the dose response relationship between dietary ZD and alterations of inflammation-related mRNA and microRNA expression in the rat esophagus. The data from the proposed studies should advance our knowledge of how Zn affects genes (mRNA and microRNAs) related to inflammation in the development and prevention of UADT cancer.

Public Health Relevance

Upper aerodigestive tract (UADT) cancer, including esophageal squamous cell cancer and oral cancer, is a deadly disease. This project investigates the mechanism(s) by which dietary zinc affects gene (mRNA and microRNA) expression as its mechanism of chemoprevention. Our findings should advance our knowledge of the mechanistic role of zinc in UADT cancer development and prevention, as well as identify new biomarkers for improved prevention, diagnosis, and treatment.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA118560-08
Application #
8641326
Study Section
Chemo/Dietary Prevention Study Section (CDP)
Program Officer
Emenaker, Nancy J
Project Start
2005-12-01
Project End
2018-03-31
Budget Start
2014-04-01
Budget End
2015-03-31
Support Year
8
Fiscal Year
2014
Total Cost
$269,247
Indirect Cost
$95,539
Name
Thomas Jefferson University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
053284659
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Feith, David J; Pegg, Anthony E; Fong, Louise Y Y (2013) Targeted expression of ornithine decarboxylase antizyme prevents upper aerodigestive tract carcinogenesis in p53-deficient mice. Carcinogenesis 34:570-6
Wan, Shao-Gui; Taccioli, Cristian; Jiang, Yubao et al. (2011) Zinc deficiency activates S100A8 inflammation in the absence of COX-2 and promotes murine oral-esophageal tumor progression. Int J Cancer 129:331-45
Fong, Louise Y Y; Jiang, Yubao; Rawahneh, Maysoon L et al. (2011) Zinc supplementation suppresses 4-nitroquinoline 1-oxide-induced rat oral carcinogenesis. Carcinogenesis 32:554-60
Sun, Jin; Liu, James; Pan, Xueliang et al. (2011) Effect of zinc supplementation on N-nitrosomethylbenzylamine-induced forestomach tumor development and progression in tumor suppressor-deficient mouse strains. Carcinogenesis 32:351-8
Taccioli, Cristian; Wan, Shao-Gui; Liu, Chang-Gong et al. (2009) Zinc replenishment reverses overexpression of the proinflammatory mediator S100A8 and esophageal preneoplasia in the rat. Gastroenterology 136:953-66
Fong, Louise Y Y; Jiang, Yubao; Riley, Maurisa et al. (2008) Prevention of upper aerodigestive tract cancer in zinc-deficient rodents: inefficacy of genetic or pharmacological disruption of COX-2. Int J Cancer 122:978-89
Aqeilan, Rami I; Hagan, John P; Aqeilan, Haifa A et al. (2007) Inactivation of the Wwox gene accelerates forestomach tumor progression in vivo. Cancer Res 67:5606-10